Press Room

Latest News

2 October 2020
New Real-World Evidence Further Demonstrates the Clinical Utility of the Oncotype DX Breast Recurrence Score® Test, Beyond Clinical Risk Factors, in Guiding Chemotherapy Treatment Decisions in Patients with Early-stage Breast Cancer

29 May 2020
New Data and Society Guidelines Support Value of Oncotype DX Breast Recurrence Score® Test in Guiding Neoadjuvant Treatment Decisions for Newly Diagnosed Patients

14 May 2020
New Oncotype DX Real-world Evidence Shows for the First Time the Practice-changing Impact of TAILORx Results


2019 Archive


Canadian News

The Oncotype DX assay has recently been featured in many Canadian national and local newspapers. Below are some stories which may be of interest to you:
British Columbia Breast Cancer Patients Gain Access to Oncotype DX®

New Research Shows Genomic Testing Changes Chemotherapy Treatment Decisions

The Globe and Mail
June 22, 2014
Gene expression profiling test expands to assess colon and prostate cancers
Article discusses how genomics and the Oncotype DX test can be incorporated in breast, colon and prostate cancer care.

March 8, 2010
Ontario begins funding breast-cancer test
Ontario has begun funding a molecular test that can tell a breast-cancer patient whether they can safely skip chemotherapy.

December 4, 2009
The Oncotype DX cancer test
An overview of the Oncotype DX Breast Cancer Assay from Genomic Health®.

May 07, 2014
Oncotype DX test gives women chemotherapy choice

Global News National
April 13, 2012
Genetic testing prompts new style of preventive health Care
Breast cancer survivor Coree Hanczyk shares her story, explains the role of the Oncotype DX test in her treatment decision.

Global TV Calgary
January 29, 2013
Judge calls for province to fund cancer test 
Based on her own breast cancer experience, Alberta patient encourages public funding for genomic testing in the province.

Chatelaine
October 2012
Cancer Research: New Technologies to Know
Could genomic testing be the crystal ball of cancer treatments? Story highlights how the Oncotype DX breast cancer test can help guide chemotherapy treatment decisions.

Making cancer care smarter.™
X

This site uses cookies. These cookies collect information about how visitors use a website, for instance which pages visitors go to most often, and if they get error messages from web pages. These cookies don’t collect information that identifies a visitor. All information these cookies collect is used only to improve the website. By continuing to use this website, you agree that we can place these types of cookies on your device. For more information, please read our privacy policy.